SCHEMBL2658299

SCHEMBL2658299

COCC(C)Nc1nc(Oc2ccc(S(C)(=O)=O)cc2)nc(C(=O)O)n1

nearest known ligand 0.41

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
GCK P35557 11/20 0.41
KCNH2 Q12809 3/20 0.40
TSHR P16473 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
HSD17B10 Q99714 1/20 0.39
PTGS1 P23219 2/20 0.39
MEN1 O00255 1/20 0.39
MAPT P10636 1/20 0.39
KMT2A Q03164 1/20 0.39
PTGS2 P35354 1/20 0.39
HCAR3 P49019 2/20 0.38
CDK1 P06493 1/20 0.36
CDK2 P24941 1/20 0.36
KDR P35968 1/20 0.36
GAA P10253 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL945339 0.82 GCK (0.45) GCKKCNH2
SCHEMBL2656937 0.82 GCK (0.49) GCKKCNH2CDK1CDK2KDR
SCHEMBL2659560 0.80 GCK (0.45) GCKKCNH2HCAR3
SCHEMBL2657667 0.80 GCK (0.45) GCKKCNH2HCAR3
SCHEMBL2656837 0.80 GCK (0.43) GCKKCNH2PTGS1PTGS2HCAR3
SCHEMBL945504 0.75 GCK (0.45) GCKKCNH2SMN1; SMN2
SCHEMBL2658382 0.75 GCK (0.51) GCKKCNH2HCAR3
SCHEMBL2656881 0.72 GCK (0.51) GCKKCNH2CDK1CDK2KDR
SCHEMBL2657829 0.71 GCK (0.49) GCKKCNH2
SCHEMBL944384 0.69 GCK (0.47) GCKKCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2245025-A1 CARBOXAMIDE-HETEROARYL DERIVATIVES FOR THE TREATMENT OF DIABETES Merck Patent GmbH (DE) 2010-11-03 EP claimed
WO-2009106209-A1 CARBOXAMIDE-HETEROARYL DERIVATIVES FOR THE TREATMENT OF DIABETES MERCK PATENT GMBH (DE) 2009-09-03 WO claimed
EP-2245025-A1 CARBOXAMIDE-HETEROARYL DERIVATIVES FOR THE TREATMENT OF DIABETES Merck Patent GmbH (DE) 2010-11-03 EP disclosed
WO-2009106209-A1 CARBOXAMIDE-HETEROARYL DERIVATIVES FOR THE TREATMENT OF DIABETES MERCK PATENT GMBH (DE) 2009-09-03 WO disclosed